Union Pharmacist results, Q3 2024
Net profit, assets, equity and cash flow for Q3 2024, against the same period a year earlier, from the published financial statements.
Net profit2.34 millionEGP · −41.5% vs the same period a year earlier
Total assets46.62 millionEGP · −16.4% vs the same period a year earlier
Shareholders' equity12.19 millionEGP · −4.0% vs the same period a year earlier
Operating cash flow1.59 millionEGP · +1207.9% vs the same period a year earlier
In short
- Union Pharmacist's net profit for Q3 2024 was about 2.34 million EGP, down −41.5% from 3.99 million EGP in Q3 2023.
- Total assets at the end of Q3 2024 were about 46.62 million EGP, and shareholders' equity about 12.19 million EGP.
- Operating cash flow for Q3 2024 was positive at 1.59 million EGP.
Key lines against the same period a year earlier
This periodQ3 2023Change
Net profit2.34 million3.99 million−41.5%
Gross profit2.6 million5.66 million−54.0%
Total assets46.62 million55.74 million−16.4%
Total liabilities34.43 million43.05 million−20.0%
Shareholders' equity12.19 million12.7 million−4.0%
Total liabilities and equity46.62 million55.74 million−16.4%
Operating cash flow1.59 million122 thousand+1207.9%
Investing cash flow0——
Net change in cash1.59 million122 thousand+1207.9%
Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version. Figures are as shown in the published statement summary; quarterly figures may be cumulative from the start of the fiscal year.
Union Pharmacist's Q3 2026 results, the day they are published
One email on the day, no account, and a one-click stop in the email itself.
By subscribing you agree to receive these alerts only. Privacy policy